In the past, type 2 diabetes mellitus (T2DM) was considered as a disease of adulthood, not a paediatric condition. Over the last years, however, in the USA and the rest of the world there has been a disturbing trend of increasing cases of T2DM in children, mirroring increasing rates of obesity. Publications on prevalence of T2DM in youth, especially in the European countries are anecdotal and there are no populationbased data. It's also known that not only T2DM, but the components (abdominal type of obesity, insulin resistance-hyperinsulinaemia, impaired glucose tolerance, dyslipidaemia, hypertension) of metabolic cardiovascular syndrome (MCS) are increasing among obese children. According to our results 40 % of obese children was hypertensive, hypercholesterolaemia was found 24-26 % (male-female), while hypertrigliceridinaemia was found 44-27 % (male-female) in obese children. Only 14.4 % of obese children was free from any risk factors of MCS. In contrast to the high prevalence of the above cardiovascular risk factors, the prevalence of T2DM is relatively low (7.9/100
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A SEVERE COMPLICATION THAT SHOULD ALWAYS BE CONSIDERED
Ewa Malecka-Tendera, Dept Paediatric Endocrinology and Diabetes, Silesian School of Medicine, Katowice, Poland Type 2 diabetes mellitus (T2DM) with onset in childhood is a disease recognized for less than 20 years. During the past 10 years a dramatic increase in frequency in the occurrence of T2DM have been noted in obese children and it seems to be emerging as major public health problem for adolescents. In some countries or ethnic groups it is 5 times more common than type 1 diabetes mellitus. T2DM is often asymptomatic in its early stages or patients may have non-specific findings. This makes the early diagnosis difficult and many patients may stay unidentified for months or even years. However, several adolescents with T2DM appeared with typical symptoms of polyuria and polydipsia and some with ketoacidosis. There are very few data on the long term outcome of T2DM diagnosed in childhood. In one study Canadian children in whom diagnosis was made before the age of 17 were followed up for up to 16 years. Many of them remained untreated and 67% had poor glycemic control. The outcome was very poor with high rates of mortality, amputation, dialysis and pregnancy loss. Adolescents with T2DM are almost always obese and often have other risk factors for cardiovascular disease, the pathology which is the main reason of mortality in the adult population of Western societies. Early identification of disease and aggressive treatment together with improved screening strategies is necessary to improve the outcomes of T2DM and to prevent future cardiovascular disease in these young patients.
